NCT00110058View on ClinicalTrials.gov

Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

July 31, 2006

Conditions

Leukemia

Interventions

BIOLOGICAL

recombinant interferon alfa

BIOLOGICAL

therapeutic allogeneic lymphocytes

DRUG

cyclosporine

DRUG

fludarabine phosphate

DRUG

imatinib mesylate

DRUG

mycophenolate mofetil

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (3)

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

98109-1023

Seattle Cancer Care Alliance, Seattle

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00110058 - Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter